Mark Saldanha 's most recent trade in Marksans Pharma Ltd. was a Acquisition of 1,000,000 Equity Shares done at an average price of Rs. 74 . Disclosure was reported to the exchange on March 2, 2023 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
Mark Saldanha 's has made SAST transactions in Marksans Pharma Ltd. recently where a Acquisition of 1,000,000 shares done . Disclosure was reported to the exchange on Jan. 23, 2023.
Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Marksans Pharma | Mark Saldanha | Promoter | Acquisition | 02 Mar 2023 | 1,000,000 | 198,491,553 (43.80%) | 0.22% | 74 | 74,000,000 | 17 Feb 2023 17 Feb 2023 |
Insider Trading | Equity Shares | Conversion of security |
Marksans Pharma | Mark Saldanha & PACs | Promoter | Acquisition | 25 Jan 2023 | 1,000,000 | 198,491,733 (43.80%) | 0.22% | - | 20 Jan 2023 20 Jan 2023 |
SAST (29(2)) | - | Conv. of Warrants |